临床试验

Dapagliflozin and Right Heart Recovery After ASD Device Closure

NCT：NCT07823972 · NOT_YET_RECRUITING

NCT编号NCT07823972

状态NOT_YET_RECRUITING

开始日期2026-11-01

完成时间2029-01-30

SponsorAssiut University (OTHER)

First posted2026-09-17

Last updated2026-09-17

简要摘要

The aim of this study is to evaluate the clinical and echocardiographic influence of dapagliflozin on right ventricular reverse remodeling in adult patients following successful transcatheter Atrial Septal Defect (ASD) device closure.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。